EMBL Ventures backs Allecra Therapeutics' series B round that will support a phase 2 clinical trial for a therapy aimed at drug-resistant bacteria.

Johns Hopkins University spinout Blade Therapeutics has attracted $45m in commitments from investors including Pfizer, Novartis and Bristol-Myers Squibb.

Novo and Sofinnova Partners have co-led a series B round for Rgenix, a spinout of Rockefeller University that hopes to enter two immunotherapies into clinical trials this autumn.

Stem cell company Definigen, a Cambridge spinout, raises $2.3m to launch new pancreatic and lung stem cell products to support predictions of drug candidates before clinical trials.

Stanford-backed Autogrid, an energy management software developer, increased its overall funding to more than $40m.

Student-led investment fund Social Venture Fund invests in a second seed round for medical software-as-a-service firm Conversa Health.

Medical device startup Foundry Innovation & Research, also known as Fire1, has secured $7.5m in a round backed by existing investor Medtronic.

Allianz spinout Idinvest contributed to a series B round that will help the UK-based background checking service expand in the US.